Bishal Gyawali, Associate Professor at Queen’s University, shared post on LinkedIn:
“Our research team have had a very productive September.
Follow this thread to tag along and have a look at our major highlights from September 2025.”
Quoting BG Lab‘s post on X about their Highlights from September 2025:
“We had another productive month! Tag along for an update on our team’s major accomplishments in September!
Bishal Gyawali collaborated with CDN Cancer Trials to publish a paper in JNCI Now about baseline financial difficulty among patients participating in clinical trials and its association with mortality.
Title: Financial difficulty among patients with cancer participating in clinical trials and its association with patient survival and quality of life.
Authores: Bishal Gyawali, Nan Chen, Dongsheng Tu, Joseph Pater,
We had the pleasure of announcing the recipient of the 2025 Anita Gyawali-Ganesh Gyawali Health Research Award to Dr. Nitesh Kumar Karna!
The 24th version of the WHO List of Essential Medicines and the 10th version of the WHO List of Essential Medicines for Children were released on September 5th, of which our leader is 1 of 13 Expert Committee Members updating these lists.
Bishal Gyawali published a policy review in The Lancet about criteria for reporting health-related quality of life in clinical trials.
Title: Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer
Authors: Prof Ian F Tannock, Madeline Lee Pe, Prof Christopher M Booth, Prof Michael Brundage, Prof Nathan I Cherny, Corneel Coens, Prof Elizabeth A Eisenhauer, Jan Geissler, Johannes M Giesinger, Bishal Gyawali, Sjoukje F Oosting, Prof Gregory R Pond, Jaap C Reijneveld, Enrique Soto-Perez-de-Celis, Michelle Tregear, Prof Winette T A van der Graaf
Bishal Gyawali also published a commentary in JCO OP ASCO about the cost of convenience in cancer care!
Title: Cost of Convenience in Cancer Care
Author: Bishal Gyawali
Congratulations to our team-member Laure-Anne Teuwen on being selected for the ESMO Leadership Program!
Bishal Gyawali spoke at the SMeO25 Congress about Common Sense Oncology, critical appraisal, cancer economics and drug access.
Finally, Bishal Gyawali talked about mentorship and highlighted projects led by his trainees in 2025 for Queen’s Department of Oncology Grand Rounds.
Follow us on this account and check out our website for more updates!”
More posts featuring Bishal Gyawali on OncoDaily.